<?xml version="1.0" encoding="UTF-8"?>
<ref id="B83-vaccines-07-00045">
 <label>83.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>van Doorn</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Pleguezuelos</surname>
    <given-names>O.</given-names>
   </name>
   <name>
    <surname>Liu</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Fernandez</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Bannister</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Stoloff</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Oftung</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Norley</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Huckriede</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Frijlink</surname>
    <given-names>H.W.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Evaluation of the immunogenicity and safety of different doses and formulations of a broad spectrum influenza vaccine (FLU-v) developed by SEEK: Study protocol for a single-center, randomized, double-blind and placebo-controlled clinical phase IIb trial</article-title>
  <source>BMC Infect. Dis.</source>
  <year>2017</year>
  <volume>17</volume>
  <elocation-id>241</elocation-id>
  <pub-id pub-id-type="doi">10.1186/s12879-017-2341-9</pub-id>
  <?supplied-pmid 28376743?>
  <pub-id pub-id-type="pmid">28376743</pub-id>
 </element-citation>
</ref>
